Richard D Cummings Selected Research

Tn antigen

12/2020	Erratum to: Identification of Tn antigen O-GalNAc-expressing glycoproteins in human carcinomas using novel anti-Tn recombinant antibodies.
1/2020	O-glycan recognition and function in mice and human cancers.
1/2020	Identification of Tn antigen O-GalNAc-expressing glycoproteins in human carcinomas using novel anti-Tn recombinant antibodies.
1/2018	Molecular cloning, expression, and characterization of UDP N-acetyl-α-d-galactosamine: Polypeptide N-acetylgalactosaminyltransferase 4 from Cryptosporidium parvum.
1/2017	Biochemical characterization of functional domains of the chaperone Cosmc.
1/2014	The Cosmc connection to the Tn antigen in cancer.
10/2013	Microarray analysis of the human antibody response to synthetic Cryptosporidium glycopeptides.
3/2013	WITHDRAWN: The Cosmc connection to the Tn antigen in cancer.
11/2012	Epigenetic silencing of the chaperone Cosmc in human leukocytes expressing tn antigen.
2/2011	The Tn antigen-structural simplicity and biological complexity.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard D Cummings Research Topics

Disease

32	Infections 01/2022 - 10/2002
30	Neoplasms (Cancer) 01/2022 - 03/2008
16	Inflammation (Inflammations) 01/2021 - 09/2002
8	Human Influenza (Influenza) 12/2020 - 05/2007
7	IGA Glomerulonephritis (IGA Nephropathy) 11/2014 - 12/2002
6	Schistosomiasis (Bilharziasis) 01/2016 - 05/2003
5	Carcinoma (Carcinomatosis) 12/2020 - 01/2014
5	Tn Syndrome 10/2013 - 12/2002
4	Schizophrenia (Dementia Praecox) 01/2022 - 01/2020
4	Parasitic Diseases (Parasitic Disease) 07/2014 - 06/2004
3	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2015
3	Colitis 01/2020 - 06/2007
3	Carcinogenesis 01/2019 - 10/2013
3	Autoimmune Diseases (Autoimmune Disease) 01/2017 - 10/2005
3	Influenza in Birds (Avian Flu) 01/2014 - 08/2007
2	Thrombosis (Thrombus) 01/2021 - 03/2015
2	Hemorrhage 01/2021 - 02/2004
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2020 - 03/2008
2	Crohn Disease (Crohn's Disease) 01/2020 - 03/2013
2	Ulcerative Colitis 01/2020 - 06/2007
2	Tuberculosis (Tuberculoses) 01/2019 - 03/2002
2	Colorectal Neoplasms (Colorectal Cancer) 08/2018 - 06/2007
2	Congenital Disorders of Glycosylation 01/2016 - 11/2013
2	Gastroenteritis 09/2015 - 11/2014
2	Multiple Sclerosis 07/2015 - 03/2013
2	Paramyxoviridae Infections (Parainfluenza) 09/2011 - 08/2007
1	Virus Diseases (Viral Diseases) 11/2022
1	Pathologic Processes 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 12/2021
1	Nephritis 10/2021
1	Lupus Nephritis 10/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2021
1	Lung Neoplasms (Lung Cancer) 07/2021
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2021

Drug/Important Bio-Agent (IBA)

58	Polysaccharides (Glycans)IBA 11/2022 - 03/2003
17	AntigensIBA 01/2022 - 05/2003
14	Tn antigenIBA 12/2020 - 02/2004
12	Glycoproteins (Glycoprotein)IBA 01/2022 - 09/2010
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2004
9	MucinsIBA 01/2022 - 08/2005
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
9	AntibodiesIBA 12/2020 - 01/2011
7	GlycosyltransferasesIBA 12/2021 - 12/2002
6	CarbohydratesIBA 01/2022 - 03/2003
6	EnzymesIBA 12/2020 - 10/2005
5	Galectins (Galectin)IBA 01/2022 - 02/2011
5	Immunoglobulin G (IgG)IBA 01/2020 - 02/2010
5	N-Acetylneuraminic Acid (Sialic Acid)IBA 06/2014 - 05/2007
4	Membrane Glycoproteins (Membrane Glycoprotein)IBA 12/2021 - 10/2005
4	Hemagglutinins (Hemagglutinin)IBA 12/2020 - 05/2007
4	VaccinesIBA 01/2016 - 06/2004
4	1-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA 01/2016 - 11/2008
4	EpitopesIBA 07/2014 - 10/2002
3	SugarsIBA 01/2022 - 01/2013
3	Carrier Proteins (Binding Protein)IBA 01/2022 - 02/2011
3	LipidsIBA 01/2022 - 01/2016
3	Mannose ReceptorIBA 01/2022 - 07/2015
3	Pharmaceutical PreparationsIBA 01/2021 - 01/2014
3	Neuraminidase (Sialidase)IBA 12/2020 - 08/2007
3	SelectinsIBA 01/2019 - 09/2002
3	C-Type Lectins (C-Type Lectin)IBA 01/2019 - 09/2010
3	LectinsIBA 01/2018 - 09/2006
3	GlycopeptidesIBA 07/2014 - 09/2010
3	Sialic AcidsIBA 06/2014 - 08/2007
3	CytokinesIBA 01/2014 - 01/2006
2	Cell Adhesion MoleculesIBA 01/2022 - 01/2018
2	LigandsIBA 07/2021 - 01/2020
2	P-SelectinIBA 01/2021 - 03/2015
2	Complement System Proteins (Complement)IBA 12/2020 - 01/2012
2	ManganeseIBA 12/2020 - 01/2020
2	Biological ProductsIBA 12/2020 - 03/2011
2	sialosyl-Tn antigenIBA 01/2020 - 01/2014
2	Peptides (Polypeptides)IBA 01/2020 - 09/2010
2	Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)IBA 01/2020 - 10/2013
2	Immunoglobulin M (IgM)IBA 01/2020 - 01/2018
2	Immunoglobulin A (IgA)IBA 01/2020 - 11/2014
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2020 - 01/2017
2	Mannose (D-Mannose)IBA 11/2019 - 01/2016
2	CeramidesIBA 01/2019 - 03/2002
2	Galectin 3 (LGALS3)IBA 11/2018 - 08/2004
2	Monoclonal AntibodiesIBA 01/2018 - 03/2003
2	Phenobarbital (Luminal)FDA Link 12/2016 - 05/2014
2	Indicators and Reagents (Reagents)IBA 01/2016 - 01/2014
2	Galectin 1 (LGALS1)IBA 01/2016 - 01/2014
2	GlycolipidsIBA 01/2014 - 03/2002
2	GlycoconjugatesIBA 10/2013 - 03/2003
2	OligosaccharidesIBA 09/2013 - 08/2007
2	Molecular Chaperones (Chaperone, Molecular)IBA 10/2005 - 12/2002
1	Chimeric Antigen ReceptorsIBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	Neurotransmitter Receptors (Neurotransmitter Receptor)IBA 01/2022
1	Lewis X AntigenIBA 12/2021
1	FucosyltransferasesIBA 12/2021
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 10/2021
1	CalciumIBA 10/2021
1	glycosylated IgGIBA 10/2021
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2021

Therapy/Procedure

5	Therapeutics 01/2022 - 03/2013
2	Immunomodulation 07/2015 - 01/2015